A study of Gunja taila on Migraine.

Phase 1/2

Not yet recruiting

• Conditions: Migraine, unspecified. Ayurveda Condition: ARDHAVABHEDAKA,

• Registration Number: CTRI/2023/06/054160
• Lead Sponsor: Gurukul Campus Uttrakhand Ayurved University Haridwar

Brief Summary

*Ardhavabhedaka* is a type of *Shiro-rog*, characterised by severe tearing and pricking pain in *Manya, Bhru, Shankha, Karna, Akshi* and *Lalata* which is paroxysmal in nature and is very much resembles to Migraine. In *Bhaisajyaratnavali, Acharya Govinddas Sen* has indicated *Gunja Taila nasya* in A*rdhavabhedaka*. In this study we will administered *Gunja Taila* as *Nasya* in Group A and Placebo (Roasted wheat powder capsules) in Group B.

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-07
• Last Update Posted: 2023-06-17

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• 1.Age group 16-60 years.
• 2.Patient will be selected irrespective of sex,religion,occupation,habitat etc.
• 3.Patient with any classical symptoms of Ardhavabhedak/Migraine.
• 4.Patient having recurrent attack of headache with or without nausea,vomiting,aura.
• 5.Patient fit for Nasya karma.

Exclusion Criteria

• 1.Patient unfit for Nasya karma as mentioned in Ayurvedic reference books.
• 2.Patient having history of Head Trauma.
• 3.Pregnant women and Lactating mothers.
• 4.Patient having symptoms of Ophthalmoplegic migraine and Retinal migraine.
• 5.Known cause of headache like epilepsy, cysticercosis, brain tumor.
• 6.Systemic disorders that may interfere in the line of treatment like heart disease, kidney disease, hyperthyroidism, hypothyroidism.
• 7.Secondary headache caused by meningitis, tumor, encephalitis, cervical spondylitis, refractive errors and infectious disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement will be assessed on the basis of	Outcome will be assessed at baseline, 33 day, 48 day and 63 day
subjective parameters- by Grading scale adopted for this study and MIDAS SCALE.	Outcome will be assessed at baseline, 33 day, 48 day and 63 day

Secondary Outcome Measures

Name	Time	Method
T.L.C	D.L.C

Trial Locations

Locations (1)

Gurukul Campus Uttarakhand Ayurveda University Haridwar; 🇮🇳 Hardwar, UTTARANCHAL, India

Gurukul Campus Uttarakhand Ayurveda University Haridwar

🇮🇳Hardwar, UTTARANCHAL, India

Dr Swati Bhatt

Principal investigator

9761008941

dr.swatibhatt2405@gmail.com